These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32620657)

  • 41. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma.
    Sargin SY; Ekmekcioglu O; Arpali E; Altinel M; Voyvoda B
    Urol Int; 2009; 82(3):324-9. PubMed ID: 19440022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pattern of renal cell carcinoma - a single center experience in Nepal.
    Sidharth ; Luitel BR; Gupta DK; Maskey P; Chalise PR; Sharma UK; Gyawali PR; Shrestha GK; Sayami G; Joshi BR
    Kathmandu Univ Med J (KUMJ); 2011; 9(35):185-8. PubMed ID: 22609504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study.
    Rabjerg M; Mikkelsen MN; Walter S; Marcussen N
    APMIS; 2014 Aug; 122(8):708-14. PubMed ID: 24910251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
    Erdem S; Yegen G; Telci D; Yildiz I; Tefik T; Issever H; Kilicaslan I; Sanli O
    World J Urol; 2015 Oct; 33(10):1553-60. PubMed ID: 25515319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.
    Fukushima H; Masuda H; Yokoyama M; Tatokoro M; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
    Jpn J Clin Oncol; 2013 Jul; 43(7):740-6. PubMed ID: 23729495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].
    Huang JW; Zhang J; Dong BJ; Kong W; Niu SX; Chen YH; Xue W; Liu DM; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):510-3. PubMed ID: 22967469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small renal cell carcinoma: oncological outcome with tumour size.
    Pahernik S; Huber J; Pfitzenmaier J; Haferkamp A; Hohenfellner M
    Scand J Urol Nephrol; 2011 Dec; 45(6):432-5. PubMed ID: 22017406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis.
    Corrao G; Scotti L; Bagnardi V; Sega R
    Curr Drug Saf; 2007 May; 2(2):125-33. PubMed ID: 18690958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma After Radiofrequency Ablation.
    Zhang F; Chang X; Liu T; Wang W; Zhao X; Ji C; Yang R; Guo H
    J Endourol; 2016 Jan; 30(1):37-42. PubMed ID: 26222920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study.
    Lee H; Jeong CW; Kwak C; Kim HH; Seo SI; Lee HM; Oh JJ; Lee SC; Hong SK; Lee SE; Byun SS
    Clin Genitourin Cancer; 2017 Dec; 15(6):e935-e941. PubMed ID: 28558989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.